BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9355162)

  • 21. Comorbidity of attention-deficit hyperactivity and psychoactive substance use disorders.
    Wilens TE; Biederman J; Spencer TJ; Frances RJ
    Hosp Community Psychiatry; 1994 May; 45(5):421-3, 435. PubMed ID: 8045536
    [No Abstract]   [Full Text] [Related]  

  • 22. Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: differences in phenotype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5-hydroxytryptamine-2c receptor).
    Johann M; Bobbe G; Putzhammer A; Wodarz N
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1527-34. PubMed ID: 14574222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AOD use and attention deficit/hyperactivity disorder.
    Wilens TE
    Alcohol Health Res World; 1998; 22(2):127-30. PubMed ID: 15706787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychopathology among substance abusing juvenile offenders.
    Milin R; Halikas JA; Meller JE; Morse C
    J Am Acad Child Adolesc Psychiatry; 1991 Jul; 30(4):569-74. PubMed ID: 1890090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developmental sequence from disruptive behavior diagnosis to adolescent alcohol dependence.
    Kuperman S; Schlosser SS; Kramer JR; Bucholz K; Hesselbrock V; Reich T; Reich W
    Am J Psychiatry; 2001 Dec; 158(12):2022-6. PubMed ID: 11729019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender effects on attention-deficit/hyperactivity disorder in adults, revisited.
    Biederman J; Faraone SV; Monuteaux MC; Bober M; Cadogen E
    Biol Psychiatry; 2004 Apr; 55(7):692-700. PubMed ID: 15038997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Attention deficit hyperactivity disorder outcome in adults].
    Bange F
    Arch Pediatr; 2011 Jul; 18(7):831-4. PubMed ID: 21652189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
    Sobanski E; Banaschewski T; Asherson P; Buitelaar J; Chen W; Franke B; Holtmann M; Krumm B; Sergeant J; Sonuga-Barke E; Stringaris A; Taylor E; Anney R; Ebstein RP; Gill M; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Steinhausen HC; Faraone SV
    J Child Psychol Psychiatry; 2010 Aug; 51(8):915-23. PubMed ID: 20132417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical assessment and diagnosis of adults with attention-deficit/hyperactivity disorder.
    Haavik J; Halmøy A; Lundervold AJ; Fasmer OB
    Expert Rev Neurother; 2010 Oct; 10(10):1569-80. PubMed ID: 20925472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of physicians presenting for assessment at a behavioral health center.
    McGovern MP; Angres DH; Leon S
    J Addict Dis; 2000; 19(2):59-73. PubMed ID: 10809520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence of attention-deficit hyperactivity disorder in substance addiction: from screening to diagnosis].
    Pedrero-Perez EJ; Ruiz-Sanchez de Leon JM; Rojo-Mota G; Llanero-Luque M; Puerta-Garcia C
    Rev Neurol; 2011 Mar; 52(6):331-40. PubMed ID: 21387249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychometric vs. attentional correlates of early onset alcohol and substance abuse.
    Pogge DL; Stokes J; Harvey PD
    J Abnorm Child Psychol; 1992 Apr; 20(2):151-62. PubMed ID: 1593024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender differences and conduct disorder among American Indian adolescents in substance abuse treatment.
    Fisckenscher A; Novins D
    J Psychoactive Drugs; 2003; 35(1):79-84. PubMed ID: 12733762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Children with attention deficit-hyperactive disorder (ADHD: addiction risk outsiders].
    Bischoff A
    MMW Fortschr Med; 2004 Jun; 146(23):16. PubMed ID: 15373126
    [No Abstract]   [Full Text] [Related]  

  • 35. [Psychometric properties of the French version of the Wender Utah Rating Scale and Brown's Attention Deficit Disorders Scale for adults].
    Romo L; Legauffre C; Mille S; Chèze N; Fougères AL; Marquez S; Excoffier A; Dubertret C; Adès J
    Encephale; 2010 Oct; 36(5):380-9. PubMed ID: 21035628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Links between drug and alcohol misuse and psychiatric disorders.
    Littlejohn C
    Nurs Times; 2005 Jan 4-10; 101(1):34-7. PubMed ID: 15658236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidity of alcohol and substance dependence with attention-deficit/hyperactivity disorder (ADHD).
    Ohlmeier MD; Peters K; Te Wildt BT; Zedler M; Ziegenbein M; Wiese B; Emrich HM; Schneider U
    Alcohol Alcohol; 2008; 43(3):300-4. PubMed ID: 18326548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotine and alcohol dependence in patients with comorbid attention-deficit/hyperactivity disorder (ADHD).
    Ohlmeier MD; Peters K; Kordon A; Seifert J; Wildt BT; Wiese B; Ziegenbein M; Emrich HM; Schneider U
    Alcohol Alcohol; 2007; 42(6):539-43. PubMed ID: 17766314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.
    van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA
    Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.